filings.toolsItem 1A. Risk Factors
3K characters. Original on sec.gov ·
Item 1A. Risk Factors
Certain factors that may affect the Company’s business or operations are described under “Risk Factors” in Part I, Item 1A, of the 2022 Annual Report. There have been no material changes to our risk factors from the risk factors previously disclosed in the 2022 Annual Report.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
Purchases of MetLife, Inc. common stock made by or on behalf of MetLife, Inc. or its affiliates during the quarter ended March 31, 2023 are set forth below:
| Period | Total Number of Shares Purchased (1) | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plans or Programs (2) | ||||||||||||||||||||||
| January 1 — January 31, 2023 | 3,560,346 | $ | 71.62 | 3,560,346 | $ | 950,056,916 | ||||||||||||||||||||
| February 1 — February 28, 2023 | 2,813,429 | $ | 71.52 | 2,813,429 | $ | 748,842,103 | ||||||||||||||||||||
| March 1 — March 31, 2023 | 5,239,245 | $ | 61.80 | 5,239,170 | $ | 425,057,047 | ||||||||||||||||||||
| Total | 11,613,020 | 11,612,945 |
(1)During the periods January 1 — January 31, 2023, February 1 — February 28, 2023 and March 1 — March 31, 2023, separate account index funds purchased 0 shares, 0 shares and 75 shares, respectively, of MetLife, Inc. common stock on the open market in non-discretionary transactions.
(2)In May 2022, MetLife, Inc. announced that its Board of Directors authorized $3.0 billion of common stock repurchases. At March 31, 2023, MetLife, Inc. had $425 million of common stock repurchases remaining under the authorization. Neither the authorization remaining, nor the amount repurchased, at March 31, 2023 reflects the $7 million of applicable excise tax payable in connection with such repurchases. On May 3, 2023, MetLife, Inc. announced that its Board of Directors authorized an additional $3.0 billion of common stock repurchases. For more information on common stock repurchases, including excise tax payable in connection therewith, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Liquidity and Capital Resources — The Company — Liquidity and Capital Uses — Common Stock Repurchases” and Note 13 of the Notes to the Interim Condensed Consolidated Financial Statements. See also “Risk Factors — Capital Risks — We May Not be Able to Pay Dividends or Repurchase Our Stock Due to Legal and Regulatory Restrictions or Cash Buffer Needs” included in the 2022 Annual Report.
Previous: Item 4. Controls and Procedures · Next: Item 6. Exhibits